Disclosure Panels Details Page
Genetic/Familial High-Risk Assessment: Colorectal Panel - Disclosures as of 04/16/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Lisen Axell MS | None | None | None | None | 01/04/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Carol Burke MD | Emtora biosciences Freenome inc |
guardant health Lumabridge sebela |
None | None | 09/06/2023 |
| Lee-May Chen MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. GSK |
None | None | None | 12/07/2023 |
| Daniel Chung MD | Iterative Scopes Janssen Pharmaceutica Products, LP |
Guardant | None | None | 12/09/2023 |
| Katherine Clayback MS,CGC | None | None | None | None | 03/19/2024 |
| Susan Dallas | None | None | None | None | 11/14/2023 |
| Susan Darlow PhD | None | None | None | None | 11/29/2023 |
| Zeenat Diwan PhD,MS | None | None | None | None | 12/11/2023 |
| Mary Dwyer MS | None | None | None | None | 02/12/2024 |
| Seth Felder MD | None | None | None | None | 12/01/2023 |
| Francis Giardiello MD,MBA | None | None | None | None | 02/14/2024 |
| William Grady MD | Lucid Technologies | Diacarta Guardant Health Karius Natera SEngine |
UpToDate | None | 01/21/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Samir Gupta MD | Epigenomics Freenome |
Cellmax Geneoscopy Guardant Intervenn Universal diagnostics |
None | Cellmax LLC|Epigenomics|Freenome | 11/20/2023 |
| Andrea Hagemann MD,MSCI | None | None | None | None | 11/27/2023 |
| Michael Hall MS,MD | Ambry Caris Life Sciences |
Natera | None | None | 04/15/2024 |
| Heather Hampel MS,LGC | National Cancer Institute | Carelon Genome Medical GI OnDemand |
None | None | 11/29/2023 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Rachel Hodan MS,CGC | None | None | None | None | 01/16/2024 |
| Gregory Idos MS,MD | Janssen Pharmaceutica Products, LP | None | None | None | 10/27/2023 |
| Nora Joseph MD | None | None | None | None | 01/29/2024 |
| Nawal Kassem MS,MD | None | None | None | None | 03/18/2024 |
| Bryson Katona PhD,MD | Ambry Freenome GeneDx Guardant Immunovia Invitae Janssen Pharmaceutica Products, LP Myriad Genetic Laboratories, Inc. Recursion Universal Diagnostics |
None | None | None | 11/14/2023 |
| Kaitlyn Kelly MD,MAS | None | None | None | None | 10/09/2023 |
| AnnMarie Kieber-Emmons MD | None | None | None | None | 10/08/2023 |
| Sonia Kupfer MD | None | None | None | None | 04/12/2024 |
| Xavier Llor PhD,MD | None | None | None | None | 02/16/2024 |
| Karen Lu MD | None | None | None | None | 01/29/2024 |
| Arnold Markowitz MD | None | None | None | None | 03/04/2024 |
| Mariana Moreno Prats MD | None | None | None | None | 01/30/2024 |
| Mariana Niell-Swiller MS | None | None | None | None | 10/31/2023 |
| Darryl Outlaw MD | None | None | None | None | 04/09/2024 |
| Sara Pirzadeh-Miller MS,CGC | None | None | Ambry Genetics | National Society of Genetic Counselors | 11/21/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Jewel Samadder MD | Cancer Insight Cancer Prevention Pharmaceuticals Janssen Pharmaceutica Products, LP |
Cancer Prevention Pharmaceuticals Guardant Janssen Pharmaceutica Products, LP One Two Therapeutics Recursion Pharmaceuticals |
None | None | 11/27/2023 |
| David Shibata MD,FACS,FASCRS | None | None | None | None | 03/28/2024 |
| Peter Stanich MD | Emtora Biosciences Freenome Gaurdant Invitae Corp. Pfizer Inc. PTEN Research foundation |
None | None | Collaborative Group of the Americas on Inherited Gastrointestinal Cancers | 11/18/2023 |
| Benjamin Swanson PhD,MD | None | Cogen Bioscience | None | Cogen Bioscience | 11/21/2023 |
| Brittany Szymaniak PhD,LCGC | None | "Technology-enhanced AcceleRation of Germline Evaluation for Therapy - The TARGET study" which has been funded by the Prostate Cancer Foundation. | UroGPO | None | 04/01/2024 |
| Jennifer Weiss MS,MD | Exact Sciences | None | Med Learning Group | None | 03/04/2024 |
| Jeanna Welborn MD | None | None | None | None | 02/20/2024 |
| Georgia Wiesner MD | None | None | None | None | 01/15/2024 |
| Matthew Yurgelun MD | Janssen Pharmaceutica Products, LP | Nouscom UpToDate |
None | Facing Our Risk of Cancer Empowered (FORCE) advocacy group | 03/16/2024 |